دورية أكاديمية
Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC
| العنوان: | Efficacy and safety of Daratumumab for the treatment of ABO-incompatible pure red cell aplasia after allogenic HSCT: report from SFGM-TC |
|---|---|
| المؤلفون: | Longval, ThomasAff1, IDs41409024022029_cor1, Leprêtre, Anne-Claire, Ravinet, Aurélie, Fayard, Amandine, Forcade, Edouard, Coman, Tereza, Redjoul, Rabah, Berceanu, Ana, Buchbinder, Nimrod, Berlie, Guillaume, Mappoura, Maria, Giannotti, Federica, Chevillon, Florian, Robin, Marie, Peffault de Latour, Régis, Sicre de Fontbrune, FloreAff11, IDs41409024022029_cor16 |
| المصدر: | Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 59(6):893-895 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 02683369 14765365 |
|---|---|
| DOI: | 10.1038/s41409-024-02202-9 |